JOSEPHINE OLSON: Open Payments
NPI 1750691242 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 33 payments from 11 companies in 2025. Trend: 2023 $740 · 2024 $1,418 · 2025 $563
Food & beverage: $553Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $246 |
| Amgen Inc. | 4 | $73 |
| UCB, Inc. | 2 | $57 |
| GENZYME CORPORATION | 1 | $34 |
| Lilly USA, LLC | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Incyte Corporation | 1 | $19 |
Products named: RINVOQ, Otezla, Bimzelx, SKYRIZI, DUPIXENT, TALTZ, TREMFYA, COSENTYX.
Industry payments across FL — which companies pay providers there.
